Eyal Desheh

2016

In 2016, Eyal Desheh earned a total compensation of $3.9M as Former Group Executive Vice President and Chief Financial Officer at Teva Pharmaceutical Industries, which was about the same as previous year.

Compensation breakdown

Non-Equity Incentive Plan$591,775
Option Awards$1,125,072
Salary$779,399
Stock Awards$1,124,934
Other$269,231
Total$3,890,411

Desheh received $1.1M in option awards, accounting for 29% of the total pay in 2016.

Desheh also received $591.8K in non-equity incentive plan, $779.4K in salary, $1.1M in stock awards and $269.2K in other compensation.

Rankings

In 2016, Eyal Desheh's compensation ranked 2,318th out of 14,075 executives tracked by ExecPay. In other words, Desheh earned more than 83.5% of executives.

ClassificationRankingPercentile
All
2,318
out of 14,075
84th
Division
Manufacturing
805
out of 5,488
85th
Major group
Chemicals And Allied Products
237
out of 1,900
88th
Industry group
Drugs
172
out of 1,543
89th
Industry
Pharmaceutical Preparations
134
out of 1,173
89th
Source: SEC filing on April 25, 2018.

Desheh's colleagues

We found three more compensation records of executives who worked with Eyal Desheh at Teva Pharmaceutical Industries in 2016.

2016

Michael Hayden

Teva Pharmaceutical Industries

Chief Scientific Officer

2016

Erez Vigodman

Teva Pharmaceutical Industries

Chief Executive Officer

2016

Carlo de Notaristefani

Teva Pharmaceutical Industries

Executive Vice President, Global Operations

You may also like